Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 11:47:55 2017-02-27 pm EST 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.74M 2.54M 2.31M 4.36M 292M 4.43M 30.5M 11.96M 153M 11.56M 11.31M 486M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.23M 2.99M 2.72M 5.13M 344M 5.21M 35.93M 14.09M 180M 13.62M 13.33M 573M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 2020-01-27
Director TitleAgeSince
Director/Board Member 60 2020-01-16
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
-6.60%-8.56%+42.79%+64.16% 68.98B
-4.09%-0.11%+2.31%+54.81% 53.15B
+0.03%+5.56%+10.18%+41.75% 50.83B
-1.53%+2.70%+29.72%+34.13% 44.61B
-5.97%-6.22%+258.21%+421.57% 40.57B
-1.34%+4.12%+16.05%+112.18% 42.53B
+6.53%+8.02%+15.74%+53.94% 30.95B
-0.90%-10.49%+31.48%-1.63% 25.44B
-2.76%-9.54%-16.53%-9.55% 22.66B
Average +8.34%+9.65%+43.33%+85.71% 37.97B
Weighted average by Cap. -2.43%-0.10%+44.74%+90.25%

Financials

2017 2018
Net sales 16.01K 14.23K 13.19K 12K 22.65K 1.52M 23.01K 159K 62.17K 793K 60.09K 58.81K 2.53M 124 110.22 102.16 92.95 175.4 11.77K 178.21 1.23K 481.48 6.14K 465.37 455.46 19.58K
Net income -481K -428K -396K -361K -680K -45.65M -691K -4.76M -1.87M -23.82M -1.8M -1.77M -75.93M -976K -867K -804K -731K -1.38M -92.59M -1.4M -9.66M -3.79M -48.32M -3.66M -3.58M -154M
Net Debt 497K 442K 409K 372K 703K 47.14M 714K 4.92M 1.93M 24.6M 1.86M 1.82M 78.43M 548K 487K 452K 411K 776K 52.04M 788K 5.43M 2.13M 27.16M 2.06M 2.01M 86.57M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-